Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
  • A61K8/41—Amines
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/04—Dispersions; Emulsions
  • A61K8/046—Aerosols; Foams
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/35—Ketones, e.g. benzophenone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
  • A61K8/37—Esters of carboxylic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
  • A61K8/42—Amides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
  • A61K8/45—Derivatives containing from 2 to 10 oxyalkylene groups
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
  • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
  • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
  • A61K8/86—Polyethers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P17/00—Drugs for dermatological disorders
  • A61P17/16—Emollients or protectives, e.g. against radiation
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
  • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
  • A61K2800/30—Characterized by the absence of a particular group of ingredients
  • A61K2800/31—Anhydrous

Definitions

• This invention relates generally to compositions applied topically to surfaces, for example skin and hair, for protection against ultraviolet radiation.
• the invention also relates to compositions and methods to improve skin feel and sunscreening capacity of such compositions.
• Sunscreen compositions are typically categorized as either aqueous or non-aqueous, i.e, anhydrous, compositions.
• Aqueous sunscreen compositions are typically creams formed as emulsions containing the active UV absorbing compounds and additional ingredients such as waterproofing agents, fragrances, emollients and other skin care ingredients.
• Non-aqueous sunscreen compositions are those that are typically solvent based compositions that can be formed as gels for topical application or sprayed on, for example from an alcohol based solution of the ingredients.
• Sprayable sunscreen compositions have become popular in recent years as a means for transporting and applying sunscreen.
• Film forming polymers are known to be added to non-aqueous sunscreen compositions to provide water resistance to these compositions after application to a surface such as skin or hair.
• Neutralizing agents have been used in connection with film forming agents contained in aqueous sunscreen emulsion formulations. See, e.g., WO 2004/071749 (Connetics Australia Pty. Ltd.) discussing limiting the amount of neutralizing agent added to aqueous formulations to preserve film forming properties.
• compositions and methods employing such neutralizing agents to provide for improved sunscreen protection would be useful.
• the invention provides an aqueous volatile solvent-based composition
• aqueous volatile solvent-based composition comprising at least one UV absorbing active ingredient and at least one film forming polymer containing a plurality of acid groups, wherein the polymer is present in an amount greater than about 1% by weight of the composition and wherein at least a portion of the acid groups have been neutralized with a neutralizing agent.
• the invention further provides a method for increasing the SPF for an aqueous volatile solvent-based composition comprising at least one sunscreen active agent and at least one film forming polymer, wherein the film forming polymer comprises a plurality of acid groups, the method comprising adding a cosmetically acceptable neutralizing agent to the composition resulting in the formation of a composition containing at least one sunscreen active agent and a film forming agent wherein at least a portion of the acid groups are neutralized by a cosmetically acceptable neutralizing agent, and wherein the film forming agent is present in an amount greater than 1% by weight of the final composition.
• the invention also provides a method for increasing the SPF of an aqueous volatile solvent-based composition comprising at least one sunscreen active agent, which comprises adding to the composition a film forming polymer containing a plurality of acid groups and a cosmetically acceptable neutralizing agent, resulting in the formation of a composition containing said at least one sunscreen active agent and a film forming agent wherein at least a portion of the acid groups are neutralized by said neutralizing agent, wherein the film forming polymer is present in an amount greater than 1% by weight of the final composition.
• the invention further provides a method for increasing the SPF of an aqueous volatile solvent-based composition comprising at least one sunscreen active agent, which comprises contacting a film forming polymer containing a plurality of acid groups with a cosmetically acceptable neutralizing agent to form a neutralized film forming agent wherein at least a portion of the acid groups are neutralized by said neutralizing agent, and adding to the composition comprising at least one sunscreen active agent the neutralized film forming agent, resulting in the formation of a composition containing said at least one sunscreen active agent and said neutralized film forming agent, wherein the film forming agent is present in an amount greater than 1% by weight of the final composition.
• the invention further provides a method for reducing the deleterious effects of UV radiation that contacts a surface which comprises applying to the surface the compositions of the invention.
• the invention also provides a method for preventing or reducing the occurrence of erythema on a subject due to exposure to UV radiation which comprises applying the composition of the invention to the subject prior to exposure to UV radiation.
• the invention also provides a method for preventing or reducing the occurrence of phototoxic or photoallergic reactions in a subject due to exposure to UV radiation which comprises applying the composition of the invention to the subject prior to exposure to UV radiation.
• the invention provides an aqueous volatile solvent-based composition
• aqueous volatile solvent-based composition comprising at least one UV absorbing active ingredient and at least one film forming polymer containing a plurality of acid groups, wherein the polymer is present in an amount greater than 1% by weight of the composition and wherein at least a portion of the acid groups have been neutralized with a cosmetically acceptable neutralizing agent.
• the amine-based neutralizing agents of the invention can comprise a primary, secondary, or tertiary amine containing one or more hydrocarbon chains having at least 3 carbon atoms.
• the neutralizing agent of the invention comprises one or more amines of the structure I:
• R 1 is H or a C 3 -C 36 , in another embodiment, C 3 -C 24 , and in still another embodiment, C 6 -C 18 straight chain, branched or cyclic alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group
• R 2 , R 3 are independently selected from H, CH 3 , or a C 2 to about C 36 straight chain, branched or cyclic alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group, provided that R 1 , R 2 , and R 3 are not all H.
• the alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, and aralkynyl group may optionally comprise one or more heteroatoms including S, N, O, and Si.
• the one or more side chains (R 1 , R 2 and R 3 ) will contain six or more carbon atoms (total of all chains). In another embodiment one chain will contain six or more carbon atoms.
• R 4 , R 5 , R 6 , and R 7 are independently selected from H, CH 3 , or a C 2 to about C 36 straight chain, branched or cyclic alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group.
• the alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, and aralkynyl group may optionally comprise one or more heteroatoms including S, N, O, and Si.
• R 6 is H or CH 3 ;
• R 7 is H or C 2 H 5 .
• the amine-based neutralizing agent is selected from one or more compounds of structures II and/or III:
• R 8 , R 9 , R 10 , R 11 , R 12 are independently H, CH 3 , or a C 2 to about C 36 straight chain, branched or cyclic alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group.
• the alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, and aralkynyl group may optionally comprise one or more heteroatoms including S, N, O, and Si.
• the neutralizing agent of the invention may also comprise amine groups contained within or pendant from additional molecules, such as a monomer unit within a larger polymer or pendant from a polymer backbone.
• neutralizing agent may comprise primary or secondary amines as pendant groups or monomer units wherein the amines can be optionally substituted with C 2 to a C 36 straight chain, branched or cyclic alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group.
• the alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, and aralkynyl group may optionally comprise one or more of S, N, O, or Si.
• the polymer backbone contemplated herein may comprise, for example, a silicone polymer or acrylic acid polymer.
• each of n, x, y, and z are independently from 0 up to 100, up to 90, up to 80, up to 70, up to 60, up to 50, up to 40, up to 30, up to 20, or up to 10.
• R 1 , R 2 , R 3 , and R 4 will independently comprise moieties having up to 50 carbon atoms.
• R 1 -R 12 will independently comprise moieties having up to 40 carbon atoms.
• R 1 -R 12 will independently comprise moieties having up to 30 carbon atoms.
• R 1 -R 12 will independently comprise moieties having up to 20 carbon atoms.
• amine neutralizing agents appropriate for this invention are alkyl amines, alkenyl amines, dialkyl amines, dialkenyl amines, dimethyl alkyl amines (alkyl being stearyl, tallow, cocoyl, soy etc,), methyl dialkyl amines (alkyl being stearyl, hexadecyl, tallow) and trialkyl amines, dimethyl alkenyl amines (alkenyl being soy, oleic, linoleic and linolenic), methyl dialkenyl amines and trialkenyl amines and combinations thereof.
• the amine neutralizing agent acts to neutralize at least a portion of the acid groups, e.g., carboxylic, sulfonic, phosphoric or similar acid groups, on the film forming polymer.
• the film forming polymer can be partially neutralized or fully neutralized by the neutralizing agent. In certain example embodiments between about 5% and about 100% the acid groups on the film forming polymer will be neutralized. In other example embodiments up to about 90%, up to about 80%, up to about 70%, up to about 60%, up to about 50%, up to about 40%, up to about 30%, up to about 25%, up to about 20%, up to about 15%, up to about 10% or up to about 5% of the acid groups on the film forming polymer will be neutralized.
• the amount of amine neutralizing agent to be added to obtain the desired percent neutralization of the polymer film forming agent can be determined based on the acidity of the polymer and the neutralization equivalent of the amine neutralizing agent. For example, the following equation can be used to determine the precise amount of neutralizing agent:
• A acidity ⁇ ⁇ of ⁇ ⁇ polymer ⁇ ⁇ film ⁇ ⁇ former ⁇ ⁇ ( meq ⁇ / ⁇ g )
• N % ⁇ ⁇ of ⁇ ⁇ desired ⁇ ⁇ neutralization
• E neutralization ⁇ ⁇ equivalent ⁇ ⁇ of ⁇ ⁇ amine ⁇ ⁇ ( g ⁇ / ⁇ eq )
• the acidity of particular film forming agents is readily available.
• the acidity of the film forming polymer DERMACRYL® 79 is 2.27 meq/g.
• the neutralization equivalent (E) for various amine neutralizing agents is also readily available. Examples of some Armeen® and Ethomeen® amine neutralizing agents is shown in Table 1 below.
• the amine neutralizing agent may be combined with the film forming polymer to provide a partially or fully neutralized polymer to be added later to the remainder of the composition.
• the amine neutralizing agent may be added with the film forming polymer as part of the composition, accomplishing the partial or complete neutralization in situ.
• the film forming polymer comprises at least 5% by weight of an acid-containing monomer. In additional example embodiments, the film forming polymer comprises at least 5% by weight of an carboxylic acid-containing monomer. Non-limiting examples of these monomers are acrylic acid, crotonic acid, methacrylic acid, maleic acid, itaconic acid and combinations and mixtures thereof. Additional film forming polymers, either synthetic or natural can be used with the acid containing polymers described above.
• Non-limiting examples of these additional film forming polymers are: from National Starch and Chemical Company, AMPHOMER® and AMPHOMER® LV-71 polymers (octylacrylamide/acrylates/butylaminoethyl methacrylate compolymer), AMPHOMER HC® polymer (acrylates/octylacrylamide copolymer) BALANCE® 0/55 and BALANCE CR® polymers (acrylates copolymer), BALANCE® 47 polymer (octylacrylamide/butylaminoethyl methacrylate copolymer), RESYN® 28-2930 polymer (VA/crotonates/vinyl neodecanoate copolymer), RESYN® 28-1310 polymer (VA/Crotonates copolymer), FLEXAN® polymers (sodium polystyrene sulfonate), DynamX polymer (polyurethane-14 (and) AMP-Ac
• Additional natural film forming polymers are native starch as used herein, also starches derived from a plant obtained by standard breeding techniques including crossbreeding, translocation, inversion, transformation or any other method of gene or chromosome engineering to include variations thereof.
• starch derived from a plant grown from artificial mutations and variations of the above generic composition which may be produced by known standard methods of mutation breeding, are also suitable herein.
• the film forming polymer may comprise a blend of two of more polymers.
• a blend of polymers may be used, wherein at least one of the polymers contains a carboxylic acid monomer and the level of carboxylic acid monomer is no less than 5% of the total polymer (by weight dry basis of the total film forming polymer).
• Sunscreen compositions according to the invention are prepared as aqueous volatile solvent-based compositions, meaning non-emulsion compositions containing primarily volatile solvents and up to about 30% by weight water.
• the compositions comprise a single liquid phase that may further comprise dispersed particulates.
• the compositions of the invention contain up to about 25% by weight water or up to about 20% by weight water.
• the compositions comprise between about 10% and about 30% by weight water, between about 10% and about 25% water or between about 10% and about 20% water.
• Example volatile solvents include one or more of alcohols such as methanol, ethanol and isopropanol, volatile hydrocarbons such as isooctane, isododecane, and isohexadecane, aldehydes and volatile silicones also including volatile ketones such as acetone and methyl ethyl ketone.
• the volatile solvent is chosen from the group consisting of ethanol, methanol, isopropanol and acetone.
• the sunscreen compositions of the invention containing alcohol based solvent systems are characterized as non-aqueous solutions. However, it may be desirable to have small amount of water in the composition, for example as a processing aid or co-solvent.
• the water contents of the compositions will be no greater than about 9% water so as to prevent the active to phase separate or precipitate out of solution.
• the solvent can include an oil such as mineral or vegetable oil. The oil may be the only solvent or may be used in varying amounts as a co-solvent or as described herein as “emollients”.
• a “sunscreen active agent” or “sunscreen active” shall include all of those materials, singly or in combination, that are regarded as acceptable for use as active sunscreening ingredients based on their ability to absorb UV radiation. Such compounds are generally described as being UV-A, UV-B, or UV-A/UV-B active agents. Approval by a regulatory agency is generally required for inclusion of active agents in formulations intended for human use.
• Those active agents which have been or are currently approved for sunscreen use in the United States include organic and inorganic substances including, without limitation, para aminobenzoic acid, avobenzone, cinoxate, dioxybenzone, homosalate, menthyl anthranilate, octyl salicylate, oxybenzone, padimate O, phenylbenzimidazole sulfonic acid, sulisobenzone, trolamine salicylate, titanium dioxide, zinc oxide, diethanolamine methoxycinnamate, digalloy trioleate, ethyl dihydroxypropyl PABA, glyceryl aminobenzoate, lawsone with dihydroxyacetone, red petrolatum.
• organic and inorganic substances including, without limitation, para aminobenzoic acid, avobenzone, cinoxate, dioxybenzone, homosalate, menthyl anthranilate, octyl salicylate, oxybenzone, padimate O, phen
• sunscreen actives examples include ethylhexyl triazone, dioctyl butamido triazone, benzylidene malonate polysiloxane, terephthalylidene dicamphor sulfonic acid, disodium phenyl dibenzimidazole tetrasulfonate, diethylamino hydroxybenzoyl hexyl benzoate, bis diethylamino hydroxybenzoyl benzoate, bis benzoxazoylphenyl ethylhexylimino triazine, drometrizole trisiloxane, methylene bis-benzotriazolyl tetramethylbutylphenol, and bis-ethylhexyloxyphenol methoxyphenyltriazine, 4-methylbenzylidenecamphor, and isopentyl 4-methoxyc
• the sunscreen active agent comprises a photoprotecting effective amount of particulates of at least one inorganic pigment or nanopigment, non-limiting examples of which include titanium dioxide, zinc oxide, iron oxide, zirconium oxide, cerium oxide, or mixture thereof.
• compositions of this invention can be applied to the skin as a liquid rub on, but are most commonly applied as a spray. However, the compositions are not limited to those compositions applied to the skin primarily as a sunscreen agent. The compositions also incorporate those formulations where the sunscreen active agent is an ingredient in another topically applied composition. Some non-limiting examples are lipstick, make-up, lip-balm, eye-shadow, hair dyes and conditioners, or any application where sun protection may be deemed beneficial.
• the compositions can be stored in containers under pressure by combination with a propellant.
• the compositions thus stored can be applied by opening a valve in the container releasing the propellant and the composition, typically in a spray or mist.
• the propellant used in the composition may be any suitable gas, or combination of gasses, that can be compressed or liquefied within a dispensing spray canister, which expand or volatilize to vapor or gas form upon exposure to ambient temperature and pressure conditions to deliver the composition in an aerosol form.
• Suitable propellants include hydrocarbons having 1 to 5 carbon atoms, including but not limited to methane, ethane, propane, isopropane, butane, isobutane, butene, pentane, isopentane, neopentane, pentene, hydrofluorocarbons (HFCs), chlorofluorocarbons (CFCs), nitrogen, ethers including dimethyl ether, and any mixtures thereof.
• hydrofluorocarbons HFCs
• CFCs chlorofluorocarbons
• nitrogen ethers including dimethyl ether, and any mixtures thereof.
• the composition in the aerosol container is liquid formulation which can contain dissolved propellant, undissolved liquid propellant and gaseous propellant. All of this is under pressure due to the vapor pressure of the propellant.
• the propellant can be present in an amount up to about 90 weight percent, preferably from about 2 weight percent to about 50 weight percent, and more preferably about 5 weight percent to about 40 weight percent, more preferably at about 30 weight percent, based on the total weight of the aerosol composition.
• compositions of the present invention may contain a wide range of additional, optional components which are referred to herein as “cosmetic components”, but which can also include components generally known as pharmaceutically active agents.
• Cosmetic components include a wide range of additional, optional components which are referred to herein as “cosmetic components”, but which can also include components generally known as pharmaceutically active agents.
• CTFA Cosmetic Ingredient Handbook Seventh Edition, 1997 and the Eighth Edition, 2000, which is incorporated by reference herein in its entirety, describes a wide variety of cosmetic and pharmaceutical ingredients commonly used in skin care compositions, which are suitable for use in the compositions of the present invention.
• Examples of these functional classes disclosed in this reference include: absorbents, abrasives, anticaking agents, antifoaming agents, antioxidants, binders, biological additives, buffering agents, bulking agents, chelating agents, chemical additives, colorants, cosmetic astringents, cosmetic biocides, denaturants, drug astringents, external analgesics, film formers, fragrance components, humectants, opacifying agents, pH adjusters, plasticizers, reducing agents, skin bleaching agents, skin-conditioning agents (emollient, humectants, miscellaneous, and occlusive), skin protectants, solvents, foam boosters, hydrotropes, solubilizing agents, suspending agents (nonsurfactant), sunscreen agents, ultraviolet light absorbers, SPF boosters, waterproofing agents, and viscosity increasing agents (aqueous and nonaqueous).
• compositions of the invention may also include materials that also increase the SPF of the final composition by such mechanisms as UV radiation scattering and dispersion.
• materials are referred to herein as “UV-radiation scattering agents” and comprise materials that exhibit UV absorbing activity or exhibit no UV absorbing activity.
• UV-radiation scattering agents include polymeric materials, such as the product known as SunSpheresTM (Rohm and Haas; Philadelphia, Pa.) which are described by their manufacturer as hollow styrene/acrylates copolymer spheres manufactured by emulsion polymerization.
• the polymer spheres are said to raise SPF values across the UVA and UVB region by dispersing and/or scattering the incident UV radiation throughout the film of sunscreen present on a surface, such as human skin. It is understood that the spheres cause less UV radiation to penetrate into the skin by redirecting the radiation towards the UV-absorbing sunscreen actives in the sunscreen formulation, where the radiation reacts with the sunscreen active molecules and the energy is dissipated as heat.
• the terms “spheres” or “scattering agents” are not limited by chemical makeup or shape, but comprise any agent that produces the effect of lengthening the path of incident UV radiation, increasing the statistical likelihood that the radiation will contact a sunscreen active molecule, i.e., a UV absorbing active agent.
• UV absorbing materials may also include UV absorbing materials that also exhibit scattering properties such as ZnO (examples include Z-CoteTM products available from BASF), TiO 2 (examples include the SolaveilTM products available from Uniqema (New Castle, Del., USA)), compounds such as methylene bis-benzotriazolyl tetramethylbutylphenol, (“TinasorbTM M” available from Ciba Specialty Chemicals, Inc. (Basel, Switzerland).
• UV radiation scattering agents are typically present in the formulation in amounts up to about 25% by weight. Certain example embodiments of the invention may comprise up to about 10% by weight, preferably in ranges of about 0.5% to about 7.0% by weight, in particularly preferred ranges of 3% to about 5% by weight.
• sunless-tanning agent or “self-tanning compositions” refer to compositions which, when applied to human skin, impart thereto an appearance similar to that achieved by exposing the skin to natural or artificial sunlight.
• sunless tanning active agents are described in U.S. Pat. Nos. 6,482,397, 6,261,541, and 6,231,837.
• Such sunless tanning compositions typically comprise, in addition to an artificial tanning effective amount of a self tanning agent, effective amounts of a composition coloring agent and a cosmetically acceptable carrier adapted for topical application to human skin.
• the self tanning agents can also include those compositions generally accepted in the art for application to human skin, and which, when so applied, react therein with amino acids so as to form pigmented products. Such reactions give the skin a brown appearance similar to the color obtained upon exposing it to sunlight for periods of time sufficient to tan the skin.
• Suitable self tanning agents include, without limitation, alpha-hydroxy aldehydes and ketones, glyceraldehyde and related alcohol aldehydes, various indoles, imidazoles and derivatives thereof, and various approved pigmentation agents.
• Presently preferred herein as self tanning agents are the alpha-hydroxy aldehydes and ketones. Most preferably, the self tanning agent is dihydroxyacetone (“DHA”).
• Suitable self tanning agents include, without limitation, methyl glyoxal, glycerol aldehyde, erythrulose, alloxan, 2,3-dihydroxysuccindialdehyde, 2,3-dimethoxysuccindialdehyde, 2-amino-3-hydroxy-succindialdehyde and 2-benzylamino-3-hydroxysuccindialdehyde.
• An emollient is an oleaginous or oily substance which helps to smooth and soften the skin, and may also reduce its roughness, cracking or irritation.
• suitable emollients include mineral oil having a viscosity in the range of 50 to 500 centipoise (cps), lanolin oil, coconut oil, cocoa butter, olive oil, almond oil, macadamia nut oil, aloe extracts such as aloe vera lipoquinone, synthetic jojoba oils, natural sonora jojoba oils, safflower oil, corn oil, liquid lanolin, cottonseed oil, grape seed oil, sweet almond oil, and peanut oil.
• cps centipoise
• the emollient is a cocoglyceride, which is a mixture of mono, di- and triglycerides of cocoa oil, sold under the trade name of Myritol 331 from Henkel KGaA, or Dicaprylyl Ether available under the trade name Cetiol OE from Henkel KGaA or a C 12 -C 15 Alkyl Benzoate sold under the trade name Finsolv TN from Finetex.
• One or more emollients may be present ranging in amounts from about 1 percent to about 10 percent by weight, preferably about 5 percent by weight.
• Another suitable emollient is DC 200 Fluid 350, a silicone fluid, available Dow Corning Corp.
• emollients include squalane, castor oil, polybutene, sweet almond oil, avocado oil, calophyllum oil, ricin oil, vitamin E acetate, olive oil, silicone oils such as dimethylopolysiloxane and cyclomethicone, linolenic alcohol, oleyl alcohol, the oil of cereal germs such as the oil of wheat germ, isopropyl palmitate, octyl palmitate, isopropyl myristate, hexadecyl stearate, butyl stearate, decyl oleate, acetyl glycerides, the octanoates and benzoates of (C 12 -C 15 ) alcohols, the octanoates and decanoates of alcohols and polyalcohols such as those of glycol and glyceryl, ricinoleates esters such as isopropyl adipate, hexyl
• emollients which are solids or semi-solids at ambient temperatures may be used.
• Such solid or semi-solid cosmetic emollients include glyceryl dilaurate, hydrogenated lanolin, hydroxylated lanolin, acetylated lanolin, petrolatum, isopropyl lanolate, butyl myristate, cetyl myristate, myristyl myristate, myristyl lactate, cetyl alcohol, isostearyl alcohol and isocetyl lanolate.
• One or more emollients can optionally be included in the formulation.
• a humectant is a moistening agent that promotes retention of water due to its hygroscopic properties.
• Suitable humectants include glycerin, polymeric glycols such as polyethylene glycol and polypropylene glycol, mannitol and sorbitol.
• the humectant is Sorbitol, 70% USP or polyethylene glycol 400, NF.
• One or more humectants can optionally be included in the formulation in amounts from about 1 percent to about 10 percent by weight, preferably about 5 percent by weight.
• a dry-feel modifier is an agent which when added to an emulsion, imparts a “dry feel” to the skin when the emulsion dries.
• Dry feel modifiers can include talc, kaolin, chalk, zinc oxide, silicone fluids, inorganic salts such as barium sulfate, surface treated silica, precipitated silica, fumed silica such as an Aerosil available from Degussa Inc. of New York, N.Y. U.S.A.
• Another dry feel modifier is an epichlorohydrin cross-linked glyceryl starch of the type that is disclosed in U.S. Pat. No. 6,488,916.
• additional thickening agents such as, for instance, various Carbopols available from Noveon Co. Particularly preferred are those agents which would not disrupt the lamellar structure in the formulation of the final product, such as non-ionic thickening agents.
• additional thickening agents is well within the skill of one in the art.
• Additional natural or synthetic substances can also be added to the compositions of the invention to protect from or delay its deterioration due to the action of oxygen in the air (oxidation). They may also reduce oxidation reactions in skin tissue. Such substances prevent oxidative deterioration which may lead to the generation of rancidity and nonenyzymatic browning reaction products.
• Typical suitable substances include propyl, octyl and dodecyl esters of gallic acid, butylated hydroxyanisole (BHA, usually purchased as a mixture of ortho and meta isomers), butylated hydroxytoluene (BHT), green tea extract, uric acid, cysteine, pyruvate, nordihydroguaiaretic acid, Vitamin A, Vitamin E and Vitamin C and their derivatives.
• BHA butylated hydroxyanisole
• BHT butylated hydroxytoluene
• green tea extract green tea extract
• uric acid cysteine
• pyruvate pyruvate
• nordihydroguaiaretic acid Vitamin A
• Vitamin E and Vitamin C and their derivatives can optionally be included in the composition in an amount ranging from about 0.001 to about 5 weight percent, preferably about 0.01 to about 0.5 percent.
• Chelating agents are substances used to chelate or bind metallic ions, such as with a heterocylic ring structure so that the ion is held by chemical bonds from each of the participating rings.
• Suitable chelating agents include ethylene diaminetetraacetic acid (EDTA), EDTA disodium, calcium disodium edetate, EDTA trisodium, albumin, transferrin, desferoxamine, desferal, desferoxamine mesylate, EDTA tetrasodium and EDTA dipotassium, or combinations of any of these.
• Fragrances are aromatic substances which can impart an aesthetically pleasing aroma to the sunscreen composition.
• Typical fragrances include aromatic materials extracted from botanical sources (i.e., rose petals, gardenia blossoms, jasmine flowers, etc.) which can be used alone or in any combination to create essential oils.
• alcoholic extracts may be prepared for compounding fragrances.
• One or more fragrances can optionally be included in the sunscreen composition in an amount ranging from about 0.001 to about 5 weight percent, preferably about 0.01 to about 0.5 percent by weight.
• preservatives may also be used if desired and include well known preservative compositions such as benzyl alcohol, phenyl ethyl alcohol and benzoic acid, diazolydinyl, urea, chlorphenesin, iodopropynyl and butyl carbamate, among others.
• compositions of the invention can further comprise skin protectant active agents.
• skin protectant active agents include (with preferred weight percent ranges), Allantoin (0.5 to 2 percent); Aluminum hydroxide gel (0.15 to 5 percent); Calamine (1 to 25 percent); Cocoa butter (greater than 50); Cod liver oil (5 to 14 percent); Colloidal oatmeal; Dimethicone (1 to 30 percent); Glycerin (20 to 45 percent); Hard fat (greater than 50); Kaolin (4 to 20 percent); Lanolin (12.5 to 50 percent); Mineral oil (greater than 50 percent); Petrolatum (greater than 30 percent); Sodium bicarbonate; Topical starch (10 to 98 percent); White petrolatum (greater than 30 percent); Zinc acetate (0.1 to 2 percent); Zinc carbonate (0.2 to 2 percent); and Zinc oxide (1 to 25 percent).
• compositions of the invention may further include insect repelling components.
• insect repelling active agent for personal care products is N,N-Diethyl-m-toluamide, frequently called “DEET” and available in the form of a concentrate containing at least about 95 percent DEET.
• Other synthetic chemical repellents include ethyl butylacetylaminoproprionate (also known as IR 3535), dimethyl phthalate, ethyl hexanediol, indalone, di-n-propylisocinchoronate, bicycloheptene, dicarboximide and tetrahydrofuraldehyde.
• Certain plant-derived materials also have insect repellent activity, including citronella oil and other sources of citronella (including lemon grass oil), limonene, rosemary oil and eucalyptus oil.
• Choice of an insect repellent for incorporation into the sunscreen emulsion will frequently be influenced by the odor of the repellent.
• the amount of repellent agent used will depend upon the choice of agent; DEET is useful at high concentrations, such as up to about 15 percent or more, while some of the plant-derived substances are typically used in much lower amounts, such as 0.1 percent or less.
• Topical application of the compositions of the invention described herein to the hair or skin of a human will provide enhanced protection against deleterious effects of ultraviolet radiation (UVR).
• UVR ultraviolet radiation
• the subject invention further provides a method for protecting human skin and/or hair against the deleterious effects of solar radiation, more particularly UVR, which method comprises topically applying thereto an effective amount of the compositions as described herein.
• An esthetically beneficial result of exposure of skin to UVR i.e., light radiation wavelengths of from 280 nm to 400 nm
• Another benefit of sun exposure comes from production of vitamin D within the skin.
• UVR is typically divided into UV-A (light wavelengths from 320 to 400 nm) and UV-B (wavelengths ranging from 280 to 320 nm) regions.
• Overexposure to UV-B irradiation is generally understood to lead to skin burns and erythema.
• overexposure to UV-A radiation may cause a loss of elasticity of the skin and the appearance of wrinkles, promoting premature skin aging.
• Such irradiation promotes triggering of the erythemal reaction or amplifies this reaction in certain individuals and may even be the source of phototoxic or photoallergic reactions. It is increasingly believed that overexposure to UV-A may also lead to melanoma.
• the application of the compositions of the invention to the skin and/or hair of an individual will provide enhanced UVR photoprotection (UV-A and/or UV-B) of the skin and/or hair of the individual.
• the sunscreen containing compositions of the invention are intended to provide a sun protection factor (SPF) rating of at least 2, with additional preferable embodiments having a sun protection factor of at least 5, in another embodiment at least 10, in another embodiment at least 15, in another embodiment at least 20, in another embodiment at least 25, in another embodiment at least 30, in another embodiment at least 35, in another embodiment at least 40, in another embodiment at least 45, in another embodiment at least 50, in another embodiment at least 55, in another embodiment at least 60, in another embodiment at least 65, in another embodiment at least 70, in another embodiment at least 75, in another embodiment at least 80, in another embodiment at least 85, in another embodiment at least 90, in another embodiment at least 95, and in another embodiment at least 100.
• the sunscreen containing compositions of the invention are also intended to provide U.S.
• the SPF for the composition containing the partially or fully neutralized film forming agent may be greater than 125 percent of the composition containing un-neutralized film forming agents.
• the SPF for the composition containing the partially or fully neutralized film forming agent may be greater than 150 percent of the un-neutralized formulation, greater than 200 percent of the un-neutralized formulation, or greater than 300 percent of the un-neutralized formulation.
• an SPF greater than 125 percent of un-neutralized SPF is equivalent to saying the SPF for a composition containing the partially or fully neutralized polymer is greater than 1.25 times that which would be achieved using an un-neutralized formulation.
• a sunscreen composition was prepared containing amine neutralizing agents and film forming polymer as follows. To a 250 ml beaker was added 3.0 g Avobenzone, 5.0 g Octisalate, 6.0 g Oxybenzone, 15.0 g Homosalate, and 1.0 g of Glycerine to a stirred solution containing 0.51 g of Dimethylstearylamine and 3.0 g of Dermacryl 79 (an acrylate copolymer containing 14% acrylic acid, available from National Starch and Chemical Co. Bridgewater, N.J.) in 66.49 g of Ethanol. The composition was stirred until all components are dissolved. Similar compositions can be heated slightly to aid in dissolution.
• Sunscreen compositions were prepared as described above with varying levels and types of amine neutralizing agents. All compositions in this example contained Avobenzone (3.0 g), Octyl Salicylate (5.0 g), Oxybenzone (6.0 g), Homosalate (15.0 g), glycerin (1.0 g) and Dermacryl 79 (3.0 g) plus ethanol to bring the weight to 100 g.
• Three sunscreen formulations were prepared and tested for sunscreen efficacy in a human SPF assay and Very Water Resistant Assay (FDA Final Monograph Protocol 7.22).
• the three formulations are Samples 1, 9, and 10 from Table 2 above. All three formulations were Ethanol based compositions containing, 3% Avobenzone, 5% Octyl Salicylate, 6% Oxybenzone, 15% Homosalate, 1.0% glycerin, 3% Dermacryl 79 (all percentages by weight of final formulation).
• the three formulations differed with respect to the percent neutralization of carboxylic acid groups of the film forming agent. Sample 1 had 0% neutralization, Sample 9 had 25% neutralization and Sample 10 had 50% neutralization.
• the amine neutralizing agent used for Samples 9 and 10 was dimethylstearylamine, which was added in an amount to achieve the desired neutralization level.
• the SPF testing on each sample was conducted (according to Protocol 7.22) by first measuring the pre-immersion (static) average SPF, carrying out the immersion procedure, and then a second measurement post immersion to calculate very water resistant average SPF. Five subjects were tested for each sample. Results are shown in Table 4.
• compositions of the invention provide a substantially increased in vivo SPF based on the presence of the amine-neutralized film forming agent and the formulations withstood Very Water Resistant Assay testing.
• Sample 9 (comprising 25% neutralization) showed an SPF of 178% (pre-immersion) and 191% (post-immersion) of the SPF of Sample 1.
• Sample 10 (comprising 50% neutralization) showed an SPF of 246% (pre-immersion) and an SPF of 268% (post immersion) of the SPF of Sample 1.
• the data demonstrate the compositions of the invention are very water resistant sunscreen compositions based on the negligible differences between the pre- and post-immersion SPF values.
• Table 5 describes example formulations comprising water content of 30% and percent neutralization of film forming agent (e.g. Dermacryl 79) of 25%.
• film forming agent e.g. Dermacryl 79
• the Part B components water and glycerin are then to the mixture of Part A.
• the sunscreen actives of Part C are then added and mixed until dissolved.
• the particulate sunscreen actives of Part D (if included) are added to the mixture until dispersed.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Birds (AREA)
• Epidemiology (AREA)
• Emergency Medicine (AREA)
• Dermatology (AREA)
• Chemical & Material Sciences (AREA)
• Dispersion Chemistry (AREA)
• Toxicology (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Chemical Kinetics & Catalysis (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Organic Chemistry (AREA)
• Pharmacology & Pharmacy (AREA)
• Cosmetics (AREA)
• Compositions Of Macromolecular Compounds (AREA)
• Manufacture Of Macromolecular Shaped Articles (AREA)

Priority Applications (13)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (1)

Family

ID=42992329

Family Applications (6)

Family Applications After (5)

Country Status (11)

Cited By (3)

Families Citing this family (14)

Citations (9)

Family Cites Families (67)

• 2009
  • 2009-12-01 US US12/628,924 patent/US20100272658A1/en not_active Abandoned
  • 2009-12-01 US US12/628,916 patent/US20100272657A1/en not_active Abandoned
• 2010
  • 2010-04-26 EP EP18196257.2A patent/EP3517095A1/en not_active Withdrawn
  • 2010-04-26 BR BRPI1011765-2A patent/BRPI1011765A2/pt not_active Application Discontinuation
  • 2010-04-26 MX MX2011011380A patent/MX345130B/es active IP Right Grant
  • 2010-04-26 ES ES10714834T patent/ES2712734T3/es active Active
  • 2010-04-26 MX MX2011011382A patent/MX2011011382A/es not_active Application Discontinuation
  • 2010-04-26 CA CA2760076A patent/CA2760076A1/en not_active Abandoned
  • 2010-04-26 EP EP10714834.8A patent/EP2424623B1/en active Active
  • 2010-04-26 WO PCT/US2010/032356 patent/WO2010129215A2/en active Application Filing
  • 2010-04-26 AR ARP100101390A patent/AR076421A1/es not_active Application Discontinuation
  • 2010-04-26 EP EP10714833A patent/EP2424622A2/en not_active Withdrawn
  • 2010-04-26 AU AU2010245079A patent/AU2010245079B2/en not_active Ceased
  • 2010-04-26 WO PCT/US2010/032354 patent/WO2010129213A2/en active Application Filing
  • 2010-04-26 JP JP2012507461A patent/JP2012525333A/ja not_active Withdrawn
  • 2010-04-26 JP JP2012507463A patent/JP5840601B2/ja not_active Expired - Fee Related
  • 2010-04-26 CA CA2760065A patent/CA2760065C/en active Active
  • 2010-04-26 AR ARP100101391A patent/AR076422A1/es not_active Application Discontinuation
  • 2010-04-26 BR BRPI1011763A patent/BRPI1011763A2/pt not_active IP Right Cessation
  • 2010-04-27 TW TW099113369A patent/TW201103565A/zh unknown
  • 2010-04-27 TW TW099113371A patent/TWI511747B/zh not_active IP Right Cessation
  • 2010-04-27 TW TW104125137A patent/TWI602579B/zh not_active IP Right Cessation
• 2012
  • 2012-02-17 US US13/398,930 patent/US20120195839A1/en not_active Abandoned
• 2014
  • 2014-01-24 US US14/163,543 patent/US10039700B2/en active Active
• 2015
  • 2015-02-17 US US14/623,983 patent/US20150157543A1/en not_active Abandoned
• 2018
  • 2018-07-16 US US16/035,762 patent/US20180318193A1/en active Pending

Patent Citations (9)

Also Published As

Similar Documents

Legal Events